In this paper, we present a normally-off GaN-based transistor with an extremely low on-resistance (R
on) fabricated by using a Ge-doped n++-GaN layer for ohmic contacts. We developed a novel GaN regrowth technique using Ge as a dopant, which achieved an extremely high doping concentration of 1 × 1020 cm−3, and thereby the lowest specific contact resistance of 1.5 × 10−6 Ω·cm2. The NiO gate fabricated using an atomic layer deposition technique reduced the spacing between the source and drain electrodes. The fabricated device showed the record-breaking R
on of 0.95 Ω·mm with the maximum drain current and transconductance of 1.1 A/mm and 490 mS/mm, respectively. Note that the obtained threshold voltage was 0.55 V. This extremely low R
on characteristic indicates the great potential of NiO-gate GaN-based heterojunction field-effect transistors.
AbstractsIn this paper, we present a normally-off GaN-based transistor with extremely low on-state resistance fabricated by using Ge-doped n ++ GaN layer for ohmic contact. We developed a new GaN regrowth technique using Ge, which achieved extremely high doping level of 1 x 10 20 cm -3 , and thereby the lowest specific contact resistance of 1.5 x 10 -6 Ω·cm 2 . Selectively deposited NiO gate using Atomic Layer Deposition (ALD) technique contributed to shorten the spacing between source and drain, making normally-off characteristics even with the 30% Al mole fraction of AlGaN. The fabricated device showed the record-breaking R on of 0.95 Ω·mm with maximum drain current (I d,MAX ) and transconductance (g m ) of 1.1 A/mm and 490 mS/mm, respectively. It is noted that the obtained V th was 0.55 V. An on/off current ratio of 5 x 10 6 is also achieved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.